Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2010
12/02/2010CA2762203A1 Simian adenovirus 41 and uses thereof
12/02/2010CA2761817A1 Production of glycoproteins
12/02/2010CA2761629A1 Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia
12/01/2010EP2256206A1 Method and gene for imparting or enhancing nonspecific adherence and/or aggregability to microorganism
12/01/2010EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256203A1 IL-23 and its receptor; related reagents and methods
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256189A1 Process for producing a plant storage organ in which a GLP-1 derivative recombinant protein is highly produced.
12/01/2010EP2256186A1 Myocardial grafts and cellular compositions
12/01/2010EP2256132A1 Method of detecting proBNP with a monoclonal antibody binding to the amino acids 38-44
12/01/2010EP2256131A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
12/01/2010EP2256130A1 Novel insulin derivatives
12/01/2010EP2256129A1 Insulin derivatives
12/01/2010EP2256127A2 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/01/2010EP2255832A2 IFBM's to promote attachment of target analytes
12/01/2010EP2255826A2 Neisserial vaccine compositions comprising a combination of antigens
12/01/2010EP2255005A2 Use of synthetic scaffolds for the production of biosynthetic pathway products
12/01/2010EP2255003A2 Drought and heat tolerance in plants
12/01/2010EP2254993A1 Protein nanocarriers, process for obtaining them and applications
12/01/2010EP2254908A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
12/01/2010EP2254907A1 Lxr ligand binding domain (lxr lbd) crystals
12/01/2010EP2254906A1 Protease stabilized, acylated insulin analogues
12/01/2010EP2254905A2 Protease-stabilized insulin analogues
12/01/2010EP2254904A2 Oligopeptidic compounds and uses thereof
12/01/2010EP2254903A2 Escherichia coli immunogens with improved solubility
12/01/2010EP2254902A1 Recombinant bacteria with e. coli hemolysin secretion system and increased expression and/or secretion of hlya, process of manufacturing and uses thereof
12/01/2010EP2254592A2 Mhc multimers in borrelia diagnostics and disease
12/01/2010EP2076532B1 Cytokine derivatives
12/01/2010EP1869071B1 Tnf-alpha binding polypeptide, uses thereof and methods employing it
12/01/2010EP1863920B1 Method for improved isolation of recombinantly produced proteins
12/01/2010EP1725583B1 Methods for increasing protein polyethylene glycol (peg) conjugation
12/01/2010EP1654282B1 Gelatin capsules
12/01/2010EP1648502B1 Hcv vaccines
12/01/2010EP1629092B1 CRYSTALLOGRAPHIC STRUCTURE OF TRYPANOSOMA CRUZI PROLINE RACEMASE (TcPRACA) AND USES THEREOF
12/01/2010EP1589106B1 Adiponectin receptor and gene coding for the same
12/01/2010EP1576103B1 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/01/2010EP1513552B1 Packaged virus-like particles in combination with cpg for use as adjuvants with allergens : method of preparation and use
12/01/2010EP1449850B1 Human cdr-grafted antibodies and antibody fragments thereof
12/01/2010EP1423425B1 Receptor, the use thereof, and mouse antibodies
12/01/2010EP1373301B1 Reducing the immunogenicity of fusion proteins
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010EP1027428B1 Alpha-amylase mutants
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1824675B Neisserial antigens
12/01/2010CN1809584B Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof
12/01/2010CN1784493B Modified beta-lactamases and uses thereof
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN101903526A Organic compounds
12/01/2010CN101903524A Pathogen control genes and methods of use in plants
12/01/2010CN101903400A Insulinotropic peptide synthesis using solid and solution phase combination techniques
12/01/2010CN101903399A Clostridial toxin netb
12/01/2010CN101903398A Edible product having an immunostimulating effect
12/01/2010CN101903044A Antibodies specific for human hepcidin
12/01/2010CN101903043A Modified influenza virus
12/01/2010CN101899489A Method for modeling production of fusion protein by utilizing trans-splicing of intein
12/01/2010CN101899469A Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
12/01/2010CN101899446A Method for preparing recombinant duck alpha-interferon
12/01/2010CN101899444A Full-length polynucleotide sequence for coding chicken II-type collagen and application thereof
12/01/2010CN101899109A Synthesis method of 4-amino azobenzene artificial antigen
12/01/2010CN101899108A Novel polypeptide based on human TLR9 receptor functional domain segment LRR11 and applications thereof
12/01/2010CN101899107A Assistant regulation and control effect of RACK1b gene on plant drought and salt resistance and application
12/01/2010CN101899106A Trimeric binding proteins for trimeric cytokines
12/01/2010CN101899105A Recombinant erythropoietin and preparation method thereof
12/01/2010CN101899104A Low molecular weight peptide of shark cartilage angiogenesis inhibiting factor, production purifying method and application thereof
12/01/2010CN101899103A Plant drought-resistance and salt-tolerance associated protein TaNAC, and encoding gene and application thereof
12/01/2010CN101899102A Method for separating high purity phycocyanin from spirulina
12/01/2010CN101899101A Synthetic polypeptide for researching influenza virus subunit vaccine
12/01/2010CN101899100A Anti-HIV-I (Human Immunodeficiency Virus-I) polypeptides as well as coding sequences and applications thereof
12/01/2010CN101899099A X4 peptide synthetic product and application thereof
12/01/2010CN101899093A X2 polypeptide synthesis product and application thereof.
12/01/2010CN101538571B Method for preparing recombinant human keratinocyte growth factor-2 by secretion expression
12/01/2010CN101260403B Plant strong salt-resistant gene AtNHXS1 and its coding protein and application
12/01/2010CN101157728B ERK2 combination polypeptide and preparation thereof
12/01/2010CN101085812B SARS coronavirus polypeptide antigen and application thereof
12/01/2010CN101058808B Breast cancer relevant p60 gene, coding protein and application thereof
11/2010
11/30/2010US7842854 Expression vector comprising nucleotide sequences coding polypeptides for generation and propagation of drought, freeze and salt resistant plants
11/30/2010US7842853 Transgenic plants synthesizing high amylose starch
11/30/2010US7842851 Floral transition genes in maize and uses thereof
11/30/2010US7842798 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines
11/30/2010US7842797 Human CDR-grafted antibody and antibody fragment thereof
11/30/2010US7842796 PUFA polyketide synthase systems and uses thereof
11/30/2010US7842795 Nucleic acids encoding a heme binding protein polypeptide
11/30/2010US7842788 Metalloproteinase specific immunoglobulin for use in treatment and prevention of degradative diseases of connective tissue
11/30/2010US7842786 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1
11/30/2010US7842785 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842783 Mouse spermatogenesis genes related to human male sterility
11/30/2010US7842781 purified polynucleotide; genomic mycobacterial DNA libraries in an alternative type of vectors, Bacterial Artificial Chromosome; resulting BAC clones could maintain large mycobacterial DNA inserts; 70% of the clones contained inserts in the size of 25 to 104 kb; probes or primers; stringent hybridization
11/30/2010US7842669 administering to the site of the full thickness defect of articular cartilage, an osteochondral graft , an active growth factor e.g. purified bone morphogenetic protein (BMP) and a suitable carrier for the regeneration of the cartilage
11/30/2010US7842667 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
11/30/2010US7842666 Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration
11/30/2010US7842664 Synthetic lipid mixtures for the preparation of a reconstituted surfactant
11/30/2010US7842663 activins (ActRIIB), for modulating (promoting or inhibiting) growth of tissue such as bone, cartilage, muscle, fat, and/or neuronal tissue; fusion proteins which inhibit signaling by myostatin and/or growth differentiation factor 11 in cell-based assay; drug screening; pharmacokinetics
11/30/2010US7842661 Glycopegylated erythropoietin formulations
11/30/2010US7842502 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis
11/30/2010US7842488 Polynucleotides encoding a human 3-phosphoinositide- dependent protein kinase
11/30/2010US7842483 Cytochrome c oxidase enzyme complex
11/30/2010US7842480 Protein fusion comprising transport domain for use in treatment and prevention of viral inection and cell proliferative disorders